Aspect Partners’s DexCom DXCM Stock Holding History

Aspect Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08K	Buy	16 +5	+45%	+$333	﹤0.01%	569
2026 Q1	$691	Hold	11	–	–	﹤0.01%	633
2025 Q4	$730	Buy	+11	New	+$711	﹤0.01%	654
2025 Q3	–	Sell	-3	Closed	-$262	–	714
2025 Q2	$262	Hold	3	–	–	﹤0.01%	591
2025 Q1	$205	Hold	3	–	–	﹤0.01%	597
2024 Q4	$233	Buy	+3	New	+$222	﹤0.01%	583
2024 Q3	–	Sell	-2	Closed	-$227	–	564
2024 Q2	$227	Buy	+2	New	+$253	﹤0.01%	554

Other funds holding DXCM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

FMI

Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Aspect Partners's DXCM Position: Q2 2026 in Review

Aspect Partners increased its DexCom (DXCM) stake by 45% in Q2 2026, buying an estimated $333 and bringing the position to 16 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #569.

Aspect Partners first reported a position in DXCM in Q2 2024 and has held it in 7 quarters since. 170 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Aspect Partners held 16 shares of DexCom worth $1.08K as of Q2 2026.
Aspect Partners bought 5 DexCom shares in Q2 2026, an estimated $333.
DexCom made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #569 holding.
Aspect Partners first reported a position in DexCom in Q2 2024 and has held it in 7 quarters since.
170 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.